Published 2 days ago • loading... • Updated 21 hours ago

Hansa Biopharma Strengthens Leadership: 25-Year Drug Development Veteran with 4 FDA Approvals Named CMO

Dr. Richard Philipson brings rare disease expertise and 4 successful drug approvals to lead Hansa's clinical development. Learn about strategic expansion plans.

This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

2 Articles

All

Left

Center

Right

pharmafile.com

Richard Philipson appointed as chief medical officer of Hansa Biopharma - Pharmafile

Hansa Biopharma has announced that Richard Philipson has been appointed chief medical officer, effective 14 July. Philipson will join the executive committee and will report to recently appointed CEO, Renée Aguiar-Lucander. Philipson brings over 25 years of experience across numerous phases of clinical development, including regulatory strategy, budgetary management and developing treatments for rare diseases. […] The post Richard Philipson appo…

21 hours ago

Read Full Article

stocktitan.net

Hansa Biopharma Strengthens Leadership: 25-Year Drug Development Veteran with 4 FDA Approvals Named CMO

Dr. Richard Philipson brings rare disease expertise and 4 successful drug approvals to lead Hansa's clinical development. Learn about strategic expansion plans.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right